clopidogrel and Angiogenesis, Pathologic

clopidogrel has been researched along with Angiogenesis, Pathologic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, K; Deguchi, K; Ikeda, Y; Kono, S; Kurata, T; Liu, N; Liu, W; Omote, Y; Yamashita, T1
Bosmans, JM; Claeys, MJ; Michiels, JJ; Van Der Goten, P; Van der Planken, MG; Vertessen, F; Vrints, CJ; Wuyts, FL1
Cazenave, JP; Herbert, JM; Klein-Soyer, C; Maffrand, JP1
Bergerat, JP; Cazenave, JP; CĂ©raline, J; Chenard, MP; Deplanque, G; Klein-Soyer, C; Mah-Becherel, MC1

Trials

1 trial(s) available for clopidogrel and Angiogenesis, Pathologic

ArticleYear
Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.
    European heart journal, 2005, Volume: 26, Issue:6

    Topics: Abciximab; Aged; Antibodies, Monoclonal; Aspirin; Clopidogrel; Coronary Angiography; Coronary Disease; Creatine Kinase; Creatine Kinase, MB Form; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Isoenzymes; Logistic Models; Male; Middle Aged; Neovascularization, Pathologic; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Premedication; Recurrence; Stents; Survival Rate; Thrombosis; Ticlopidine; Troponin T

2005

Other Studies

3 other study(ies) available for clopidogrel and Angiogenesis, Pathologic

ArticleYear
Neurovascular protection of cilostazol in stroke-prone spontaneous hypertensive rats associated with angiogenesis and pericyte proliferation.
    Journal of neuroscience research, 2014, Volume: 92, Issue:3

    Topics: Animals; Antigens; Aspirin; Cerebrovascular Circulation; Cilostazol; Clopidogrel; Disease Models, Animal; Endothelium; Fibrinolytic Agents; Male; Matrix Metalloproteinase 9; Neovascularization, Pathologic; Nerve Tissue Proteins; Pericytes; Proteoglycans; Rats; Rats, Inbred SHR; Stroke; Tetrazoles; Ticlopidine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2014
SR 25989 inhibits healing of a mechanical wound of confluent human saphenous vein endothelial cells which is modulated by standard heparin and growth factors.
    Journal of cellular physiology, 1994, Volume: 160, Issue:2

    Topics: Cell Division; Cells, Cultured; Clopidogrel; Culture Media; Endothelium, Vascular; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Heparin; Humans; Neovascularization, Pathologic; Platelet Aggregation Inhibitors; Ticlopidine; Wound Healing

1994
Anti-angiogenic effects of the thienopyridine SR 25989 in vitro and in vivo in a murine pulmonary metastasis model.
    British journal of cancer, 2002, Mar-04, Volume: 86, Issue:5

    Topics: Angiogenesis Inhibitors; Animals; Aorta; Cell Division; Clopidogrel; Disease Models, Animal; Foot; Gene Expression Regulation; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Microcirculation; Neoplasm Metastasis; Neoplasms, Experimental; Neovascularization, Pathologic; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Skin Neoplasms; Thrombospondin 1; Ticlopidine; Tumor Cells, Cultured

2002